Case Report
Morphological Characteristics of Composite Pheochromocytoma with Ganglioneuroma
Shintaro Goto, Satoko Morohashi*, Tadashi Yoshizawa, Hiroko Seino, Yunyan Wu, Toshihiro Haga and Hiroshi Kijima
Corresponding Author: Dr. Satoko Morohashi, Department of Pathology and Bioscience, Graduate School of Medicine, Hirosaki University, Zaifu-cho 5, Hirosaki, 036-8562, Japan
Received: October 16, 2018; Revised: December 20, 2018; Accepted: November 07, 2018
Citation: Goto S, Morohashi S, Yoshizawa T, Seino H, Wu Y, et al. (2018) Morphological Characteristics of Composite Pheochromocytoma with Ganglioneuroma. Biomed Res J, 2(3): 40-44.
Copyrights: ©2018 Goto S, Morohashi S, Yoshizawa T, Seino H, Wu Y, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share :
  • 1228

    Views & Citations
  • 228

    Likes & Shares

This report highlights the pathological features of composite pheochromocytoma. A 70 year old man was diagnosed with pheochromocytoma. His tumor was found to be composite pheochromocytoma with ganglioneuroma. Microscopic examination revealed an intricate mix of pheochromocytoma and ganglioneuroma. The two components were blended continuously. We believe that they are derived from common stem cells. Past literature concerning composite pheochromocytoma confirmed our hypothesis. The morphological features of composite pheochromocytoma indicate its tumorigenesis.

 

Keywords: Adrenal gland, Pheochromocytoma, Ganglioneuroma, Composite pheochromocytom
CASE PRESENTATION

A 70 year old man was referred to our hospital for examination of a left adrenal tumor. He had a history of hypertension and diabetes. Enhanced abdominal computed tomography was performed (Figure 1A). Urine examination showed a catecholamine level of 193.9 µg/day (normal range: 3-15 µg/day) and a metanephrine level of 6890 µg/day (normal range: 40-180 µg/day). 131I-metaiodobenzylguanidine (MIBG) scintigraphy imaging showed significant incorporation into the left adrenal tumor (Figure 1B). Laparoscopic left adrenalectomy was performed and complete resection of the tumor was done. After the surgery, urine catecholamine and metanephrine levels normalized. 

Macroscopy revealed a well-defined tumor coated with a fibrous capsule. The cut surface was yellowish brown. There were cystic degenerations and hemorrhage in the tissue cross-section. The tumor thrusted pre-existing normal adrenal tissue to the verge (Figure 2).

Microscopy revealed that the tumor comprised two histological types. The first component was pheochromocytoma and the second was ganglioneuroma. The two components were blended continuously and merged intricately each other (Figure 3). In the pheochromocytoma-predominant component, the tumor cells proliferated with an alveolar pattern, much like normal chromaffin cells of the adrenal medulla. Reticular fibers with abundant capillary vessels surrounded tumor nests. Tumor cells had numerous basophilic granules, which were strongly positive for chromogranin A (Figure 4). In the ganglioneuroma-predominant component, mature ganglion cells, which have large and acidophilic cytoplasm, were scattered in abundant nerve fibers. The nerve fibers were Schwann-like cells and were positive for S-100 protein (Figure 4). The Ki-67 labeling index was less than 1% for both pheochromocytoma and ganglioneuroma. The two components were quite complex and mixed in a macular pattern (Figure 4).

DISCUSSION

Composite pheochromocytoma is a rare adrenal tumor, accounting for 3% of all adrenal tumors, with less than 70 cases reported to date. It is described as pheochromocytoma with pheochromocytoma and non-pheochromocytoma components [1]. Ganglioneuroma, ganglioneuroblastoma, neuroblastoma, malignant peripheral nerve sheath tumor and neuroendocrine carcinoma are reported as histological types of non-pheochromocytoma [2-13]. In addition to the small number of cases, there are very few studies describing the pathological features of composite pheochromocytoma. Past literature has described only the histological features of composite pheochromocytoma. The relationship between pheochromocytoma and non-pheochromocytoma has not been investigated in detail and the nature of composite pheochromocytoma is largely unknown. Here we investigate the morphological features of composite pheochromocytoma in this case and discuss those mentioned in past literature.

First, we demonstrated the remarkable affinity between pheochromocytoma and ganglioneuroma. We tried to map pheochromocytoma and ganglioneuroma; however, they mixed so intricately that we could not detect their localization in detail. We also evaluated past literature on composite pheochromocytoma, particularly the studies concerning its pathological features [2-13]. We focused on the histology of the non-pheochromocytoma component, localization of pheochromocytoma and non-pheochromocytoma, state of boundaries, and presence of partition (Table 1). As a result, 5 of 13 cases showed mixed localization. Some studies did not investigate localization. From a total of 14 cases, 10 showed a blended boundary, and all cases showed no partition. Interestingly, Brady et al. [2] reported intermediate cells with characteristics of both pheochromocytoma and ganglioneuroma cells.

We hypothesized that the two components of composite pheochromocytoma arise from common stem cells. The adrenal medulla is embryologically derived from neural crest stem cells. Stem cells of the neural crest migrate into the adrenal glands and divide into two lines of differentiation. The endocrine system produces chromaffin cells and the neural system produces sympathetic ganglion cells. The adrenal medulla comprises these systems. American Forces Institute of Pathology (AFIP) describes that pheochromocytoma arising from chromaffin cells collide with ganglioneuroma arising from sympathetic ganglion cells [14]. According to this theory, the tumor should show clearly divided compartments. However, in many cases, pheochromocytoma and ganglioneuroma showed high affinity. In our opinion, they may have arisen from common stem cells before functional differentiation. Recently, a molecular pathological mechanism has been found. Kimura et al. [15] reported the loss of neurofibromin-NF1 gene product associated with the tumorigenesis of composite pheochromocytoma. According to this hypothesis, a decrease in neurofibromin induces proliferation of Schwann cells and increases in neurotrophin. Neurotrophin causes simultaneous proliferation of ganglion cells and pheochromocytes. We believe this hypothesis suggests that pheochromocytes and sympathetic ganglion cells are closely related to each other because they have a common origin (Figure 5).

We believe this hypothesis suggests that pheochromocytoma and sympathetic ganglion cells are closely related to each other because they have a common origin and composite pheochromocytoma manifests in various combinations, such as pheochromocytoma with ganglioneuroma, ganglioneuroblastoma, neuroblastoma, malignant peripheral nerve sheath tumor and neuroendocrine carcinoma, as previously reported [2-14]. Although there are also reports that nerve growth factor (NGF) affects chromaffin cells to differentiate into neural cells [16,17]. Ch’ng et al. [8] reported a case followed up for 28 years in which pheochromocytoma transformed into a malignant peripheral nerve sheath tumor. It is also possible that pheochromocytoma transforms secondarily into non-pheochromocytoma components. However, it is likely that composite pheochromocytoma arises from common stem cells because of the remarkable affinity between pheochromocytoma and ganglioneuroma in this case.

CONCLUSION

In summary, this study revealed the morphological features of composite pheochromocytoma, which were missing from many past studies. Our findings suggest that composite pheochromocytoma is derived from common stem cells. Morphology is suggestive of tumorigenesis. Nevertheless, there are few cases and pathological descriptions. Further studies should be undertaken to further reveal the nature of composite pheochromocytoma. 

1.       Lam AK (2017) Update on adrenal tumors in WHO of endocrine tumors. Endocr Pathol 28: 213-227.

2.       Brady S, Lechan RM, Schwaitzberg SD, Dayal Y, Ziar J, et al. (1997) Composite pheochromocytoma/ganglioneuroma of the adrenal gland associated with multiple endocrine neoplasia 2A: Case report with immunohistochemical analysis. Am J Surg Pathol 21: 102-108.

3.       Matias-Guiu X, Garrastazu MT (1998) Composite phaeochromocytoma-ganglioneuroblastoma in a patient with multiple endocrine neoplasia type IIA. Histopathology 32: 281-282.

4.       Juarez D, Brown RW, Ostrowski M, Reardon MJ, Lechago J, et al. (1999) Pheochromocytoma associated with neuroendocrine carcinoma. A new type of composite pheochromocytoma. Arch Pathol Lab Med 123: 1274-1279.

5.       Onozawa M, Fukuhara T, Minoguchi M, Takahata M, Yamamoto Y, et al. (2005) Hypokalemic rhabdomyolysis due to WDHA syndrome caused by VIP-producing composite pheochromocytoma: A case in neurofibromatosis type 1. Jpn J Clin Oncol 35: 559-563.

6.       Choi EK, Kim WH, Park KY (2006) A case of a composite adrenal medullary tumor of pheochromocytoma and ganglioneuroma masquerading as acute pancreatitis. Korean J Intern Med 21: 141-145.

7.       Lisewski D, Ryan S, Lim EM, Frost F, Nguyen H (2006) Concomitant composite adrenal phoechromocytoma, multiple gastric stromal tumors and pseudohermaphrodism in a patient with von Recklinghausen's disease. Int Semin Surg Oncol 26: 3-11.

8.       Ch'ng ES, Hoshida Y, Iizuka N, Morii E, Ikeda JI, et al. (2007) Composite malignant pheochromocytoma with malignant peripheral nerve sheath tumor: A case with 28 years of tumor-bearing history. Histopathology 51: 420-422.

9.       Thiel EL, Trost BA, Tower RL (2010) A composite pheochromocytoma/ganglioneuroblastoma of the adrenal gland. Pediatr Blood Cancer 54: 1032-1034.

10.    Lau SK, Chu PG, Weiss LM (2011) Mixed cortical adenoma and composite pheochromocytoma-ganglioneuroma: An unusual corticomedullary tumor of the adrenal gland. Ann Diagn Pathol 15: 185-189.

11.    Menon S, Mahajan P, Desai SB (2011) Composite adrenal medullary tumor: A rare cause of hypertension in a young male. Urol Ann 3: 36-38.

12.    Wilsher MJ (2011) Metachronous malignant composite phaeochromocytoma and pancreatic mucinous cystadenoma in a patient with neurofibromatosis type 1. Pathology 43: 170-174.

13.    Zhang BY, Zhao M, Li B, Zhang JM (2015) Diverse proportion in composite pheochromocytoma-ganglioneuroma may induce varied clinical symptom: comparison of two cases. Int J Clin Exp Pathol 8: 15369-15374.

14.    Lack EE (1997) Atlas of tumor pathology. Tumors of the adrenal gland and extra-adrenal paraganglia. Washington DC, PA: Armed Forces institute of Pathology, pp: 266-272.

15.    Kimura N, Fukase M, Wakita A, Kimura I (2002) Loss of the neurofibromin-NF1 gene product and composite pheochromocytoma. Ann N Y Acad Sci 971: 536-538.

16.    Tischler AS, DeLellis R, Biales B, Nunnemacher G, Carabba V, et al. (1980) Nerve growth factor-induced neurite outgrowth from normal human chromaffin cells. Lab Invest 43: 199-409.

17.    Tischler AS, Dichter M, Biales B, DeLellis R, Wolfe HJ (1976) Neural properties of cultured human endocrine tumor cells of proposed neural crest origin. Science 192: 902.